BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, December 6, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 16, 2021
View Archived Issues
MK2 is a therapeutic target in PDAC that mediates resistance to FIRINOX chemotherapy
Read More
Targeting cyclophilin A potentiates chemotherapeutic efficacy in chemoresistant colorectal cancer
Read More
YES1 seen to induce the growth of TNBC
Read More
Kallyope patents AMPK activators
Read More
G1 Therapeutics discloses new CDK2 inhibitors
Read More
Senda Biosciences presents AhR antagonists for cancer
Read More
Aligos Therapeutics identifies new PD-1/PD-L1 interaction inhibitors
Read More
Sinocelltech describes method for enhancing immunogenicitiy of Fc-fusion antigen
Read More
Tweaking KLF4 enhances cellular reprogramming
Read More
Targeting LIF/LIFR axis as potential therapeutic strategy against adiposity-driven TNBC
Read More
HLA-DRB1 copy number predicts response to immunosuppressive therapy in acquired aplastic anemia
Read More
One-step synthetic approach for the fabrication of oriented antibody-decorated MOF nanocrystals
Read More
Nucleoside analogue sangivamycin shows in vitro activity against several variants of SARS-CoV-2
Read More
Discovery of long-acting entecavir prodrugs
Read More
BridGene and Peter MacCallum Cancer Centre enter research collaboration for ovarian cancer
Read More
GALE is a biomarker of inherited thrombocytopenia
Read More
SAB-185 neutralizes SARS-CoV-2 Omicron variant in in vitro pseudovirus model
Read More